BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/31/2024 7:20:10 AM | Browse: 60 | Download: 161
 |
Received |
|
2024-04-30 13:01 |
|
Peer-Review Started |
|
2024-04-30 13:01 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2024-05-18 16:52 |
|
Revised |
|
2024-06-06 05:57 |
|
Second Decision |
|
2024-07-04 02:40 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2024-07-04 07:28 |
|
Articles in Press |
|
2024-07-04 07:28 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2024-07-11 20:33 |
|
Typeset the Manuscript |
|
2024-07-22 02:28 |
|
Publish the Manuscript Online |
|
2024-07-31 07:20 |
| ISSN |
2220-3230 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: Https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Infectious Diseases |
| Manuscript Type |
Minireviews |
| Article Title |
Tuberculosis in kidney transplant candidates and recipients
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Pallavi Prasad, Sourabh Sharma, Subashri Mohanasundaram, Anupam Agarwal and Himanshu Verma |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Pallavi Prasad, Visiting Professor, MBBS, MD, Assistant Professor, Department of Nephrology, Vardhman Mahavir Medical College and Safdarjung Hospital, Ansari Nagar East, Near AIIMS metro station, New Delhi 110029, Delhi, India. pallaviprasad1986@gmail.com |
| Key Words |
Tuberculosis; Latent; Antitubercular therapy; Kidney transplantation; Donor; Interferon-gamma release assays; Tuberculin; Rifampicin; Isoniazid |
| Core Tip |
The management of tuberculosis (TB) in transplant candidates and recipients is evolving rapidly. The use of new techniques for detecting TB infection (TBI) and the adoption of TBI screening by developing countries is bringing the world close to the World Health Organization's goal of ending the TB epidemic by 2030. Literature regarding the acceptance of candidates and donors after intensive phase antitubercular therapy (ATT) is now available. Fluoroquinolone-based nonrifamycin ATT has shown excellent results in transplant recipients. The review incorporates the latest guidelines and gives an overview of current evidence in the field of TB in kidney transplantation with a glimpse into the future of this field. |
| Publish Date |
2024-07-31 07:20 |
| Citation |
<p>Prasad P, Sharma S, Mohanasundaram S, Agarwal A, Verma H. Tuberculosis in kidney transplant candidates and recipients. <i>World J Transplant</i> 2024; 14(3): 96225</p> |
| URL |
https://www.wjgnet.com/2220-3230/full/v14/i3/96225.htm |
| DOI |
https://dx.doi.org/10.5500/wjt.v14.i3.96225 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
